InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 317.90
+1.20 (0.38%)
Jun 29, 2026, 5:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 173.18 million as of June 29, 2026. Its market cap has decreased by -32.30% in one year.
Market Cap
173.18M
Enterprise Value
309.35M
Revenue
270.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
317.90
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 173.18M, an increase of 2,602.19%. That is a compound annual growth rate of 23.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 173.18M | -2.13% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.76B |
| Kamada | 1.23B |
| Rekah Pharmaceutical Industry | 121.68M |
| Seach Medical Group | 79.83M |
| Together Pharma | 40.99M |
| Nextage Therapeutics | 14.73M |
| Tikun Olam-Cannbit Pharmaceuticals | 9.92M |
| PsyRX CNS Bio-Tech | 9.13M |